Eisai brings Novartis executive on oncology board
Japan | News | 0 Comment | 23 May, 2019
Eisai Inc., the U.S. pharmaceutical subsidiary of Japan headquartered Eisai Co., Ltd., has announced the immediate appoi...Read more
Takeda, Frazier Healthcare Partners to launch Phathom Pharma
Japan | News | 0 Comment | 21 May, 2019
Takeda Pharmaceutical and Frazier Healthcare Partners have announced a collaboration to launch Phathom Pharmaceuticals, ...Read more
Takeda announces results of Phase 3b VARSITY studies
Japan | News | 0 Comment | 20 May, 2019
Takeda Pharmaceutical Company Limited has announced further results from the Phase 3b head-to-head VARSITY study, w...Read more
Daiichi Sankyo fails to hold up influenza vaccine project
Japan | News | 0 Comment | 20 May, 2019
Japanese pharma company Daiichi Sankyo has announced that the Company has been unable to fulfill its obligation to build...Read more
Eisai to present data on oncology pipeline and products
Japan | News | 0 Comment | 16 May, 2019
Eisai Co., Ltd. announced that presentations on a series of abstracts highlighting updates regarding its in-house discov...Read more
Teijin and AMED to develop drugs for frail elders
Japan | News | 0 Comment | 17 May, 2019
Teijin Limited has announced that it has signed a research and development agreement with the Japan Agency for Medical R...Read more
Takeda's BLA for Vedolizumab gets approval by U.S. FDA
Japan | News | 0 Comment | 14 May, 2019
Takeda Pharmaceutical Company has announced that the U.S. Food & Drug Administration (FDA) has accepted for rev...Read more
Daiichi Sankyo launches hypertension drug in Japan
Japan | News | 0 Comment | 15 May, 2019
Daiichi Sankyo has announced the launch in Japan of MINNEBRO® Tablets 1.25 mg, 2.5 mg and 5 mg (generic name: e...Read more
Eisai to sell anti-rheumatic injection in Japan
Japan | News | 0 Comment | 14 May, 2019
Eisai Co., Ltd. has entered into a license agreement with medac Gesellschaft für klinische Spezialpräparate mb...Read more
Takeda sells surgical patch to Ethicon for $400M
Japan | News | 0 Comment | 13 May, 2019
Japan headquartered Takeda Pharma has entered into an agreement to sell TachoSil®, a surgical patch designed to achi...Read more
Novartis to acquire Xiidra in a $5.3B deal
Japan | News | 0 Comment | 10 May, 2019
Novartis announced that it has entered into an agreement with Takeda Pharmaceutical Company Limited to acquire the asset...Read more
Promethera Biosciences makes progress in HepaStem development programme
Japan | News | 0 Comment | 09 May, 2019
Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, has announced the dosing of a ...Read more
Promethera Biosciences completes €39.7 M Series D Financing
Japan | News | 0 Comment | 08 May, 2019
Promethera Biosciences, a global innovator in cell-based medicines and liver diseases has announced the closing of a &eu...Read more
Daiichi Sankyo- AstraZeneca’s breast cancer drug reveals positive response
Japan | News | 0 Comment | 08 May, 2019
Daiichi Sankyo Company, Limited (Daiichi Sankyo) and AstraZeneca have announced positive topline results for the pivotal...Read more
Eisai with UK DRI launches new Post-Doctoral programme
Japan | News | 0 Comment | 08 May, 2019
Eisai Co., Ltd. and the UK Dementia Research Institute (UK DRI) announced the launch of a joint post-doctoral programme ...Read more
Takeda collaborates with Skyhawk to develop solutions for neurodegenerative diseases
Japan | News | 0 Comment | 07 May, 2019
US based Skyhawk Therapeutics, Inc. has announced a strategic collaboration with Japan headquartered Takeda Pharmaceutic...Read more
Takeda opens new global research center in San Diego
Japan | News | 0 Comment | 03 May, 2019
Takeda has announced the opening of a new research facility in San Diego, California. Extending Takeda’s 14-year p...Read more
Takeda announces Andrey Potapov as ICMEA Area Head
Japan | News | 0 Comment | 30 Apr, 2019
Global biopharmaceutical company Takeda announced Andrey Potapov as its Area Head for India, CIS (the Commonwealth of In...Read more